Journal of Hepatology
Volume 53, Issue 2 , Pages 335-338 , August 2010

The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life

  • Stefano Romeo

      Affiliations

    • Endocrinology and Diabetes, Department of Medical Sciences, University of Cagliari, Cagliari, Italy
    • University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge, UK
    • These authors contributed equally to this work.
    • ,
  • Federica Sentinelli

      Affiliations

    • Endocrinology and Diabetes, Department of Medical Sciences, University of Cagliari, Cagliari, Italy
    • These authors contributed equally to this work.
    • ,
  • Valentina M Cambuli

      Affiliations

    • Endocrinology and Diabetes, Department of Medical Sciences, University of Cagliari, Cagliari, Italy
    • ,
  • Michela Incani

      Affiliations

    • Endocrinology and Diabetes, Department of Medical Sciences, University of Cagliari, Cagliari, Italy
    • ,
  • Tiziana Congiu

      Affiliations

    • Endocrinology and Diabetes, Department of Medical Sciences, University of Cagliari, Cagliari, Italy
    • ,
  • Vanessa Matta

      Affiliations

    • Endocrinology and Diabetes, Department of Medical Sciences, University of Cagliari, Cagliari, Italy
    • ,
  • Sabrina Pilia

      Affiliations

    • Pediatric Endocrine Unit, Regional Hospital for Microcitemia, Cagliari, Italy
    • ,
  • Isabel Huang-Doran

      Affiliations

    • University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge, UK
    • ,
  • Efisio Cossu

      Affiliations

    • Endocrinology and Diabetes, Department of Medical Sciences, University of Cagliari, Cagliari, Italy
    • ,
  • Sandro Loche

      Affiliations

    • Pediatric Endocrine Unit, Regional Hospital for Microcitemia, Cagliari, Italy
    • ,
  • Marco G Baroni

      Affiliations

    • Endocrinology and Diabetes, Department of Medical Sciences, University of Cagliari, Cagliari, Italy
    • Corresponding Author InformationCorresponding author. Address: Endocrinology and Diabetes, Department of Medical Sciences, University of Cagliari, Policlinico Universitario, 09042 Cagliari, Italy. Tel.: +39 070 6754068; fax: +39 070 51096044.

Received 30 December 2009 ,Revised 18 February 2010 ,Accepted 19 February 2010.

References 

  1. Reilly JJ, Dorosty AR. Epidemic of obesity in UK children. Lancet. 1999;354:1874–1875
  2. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960–1994. Int J Obes Relat Metab Disord. 1998;22:39–47
  3. Binkin N, Fontana G, Lamberti A, Cattaneo C, Baglio G, Perra A, et al. A national survey of the prevalence of childhood overweight and obesity in Italy. Obes Rev. 2009;11:2–10
  4. Loomba R, Sirlin CB, Schwimmer JB, Lavine JE. Advances in pediatric nonalcoholic fatty liver disease. Hepatology. 2009;50:1282–1293
  5. Burgert TS, Taksali SE, Dziura J, Goodman TR, Yeckel CW, Papademetris X, et al. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab. 2006;91:4287–4294
  6. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006;118:1388–1393
  7. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129:113–121
  8. Rafiq N, Bai C, Fang Y, Srishord M, McCullough A, Gramlich T, et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol. 2009;7:234–238
  9. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology. 1990;12:1106–1110
  10. Kotronen A, Johansson LE, Johansson LM, Roos C, Westerbacka J, Hamsten A, et al. A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans. Diabetologia. 2009;52:1056–1060
  11. Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2008;40:1461–1465
  12. Sookoian S, Castano GO, Burgueno AL, Fernandez Gianotti T, Rosselli MS, Pirola CJ. A nonsynonymous gene variant in adiponutrin gene is associated with nonalcoholic fatty liver disease severity. J Lipid Res. 2009;50:2111–2116
  13. Jenkins CM, Mancuso DJ, Yan W, Sims HF, Gibson B, Gross RW. Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities. J Biol Chem. 2004;279:48968–48975
  14. Lake AC, Sun Y, Li JL, Kim JE, Johnson JW, Li D, et al. Expression, regulation, and triglyceride hydrolase activity of Adiponutrin family members. J Lipid Res. 2005;46:2477–2487
  15. Romeo S, Sentinelli F, Dash S, Yeo GS, Savage DB, Leonetti F, et al. Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent. Int J Obes (Lond). 2010;34:190–194
  16. Tian C, Stokowski RP, Kershenobich D, Ballinger DG, Hinds DA. Variant in PNPLA3 is associated with alcoholic liver disease. Nat Genet. 2010;42:21–23
  17. Cambuli VM, Incani M, Pilia S, Congiu T, Cavallo MG, Cossu E, et al. Oral glucose tolerance test in Italian overweight/obese children and adolescents results in a very high prevalence of impaired fasting glycaemia, but not of diabetes. Diabetes Metab Res Rev. 2009;25:528–534
  18. Cacciari E, Milani S, Balsamo A, Spada E, Bona G, Cavallo L, et al. Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest. 2006;29:581–593
  19. Tanner JM. Growth and maturation during adolescence. Nutr Rev. 1981;39:43–55
  20. Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, Del Vecchio E, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002;137:1–10
  21. Strauss RS, Barlow SE, Dietz WH. Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J Pediatr. 2000;136:727–733
  22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419
  23. Kantartzis K, Peter A, Machicao F, Machann J, Wagner S, Konigsrainer I, et al. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene. Diabetes. 2009;58:2616–2623
  24. Yuan X, Waterworth D, Perry JR, Lim N, Song K, Chambers JC, et al. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am J Hum Genet. 2008;83:520–528
  25. Johansson LE, Hoffstedt J, Parikh H, Carlsson E, Wabitsch M, Bondeson AG, et al. Variation in the adiponutrin gene influences its expression and associates with obesity. Diabetes. 2006;55:826–833
  26. Johansson LE, Lindblad U, Larsson CA, Råstam L, Ridderstråle M. Polymorphisms in the adiponutrin gene are associated with increased insulin secretion and obesity. Eur J Endocrinol. 2008;159:577–583
  27. Joy D, Thava VR, Scott BB. Diagnosis of fatty liver disease: is biopsy necessary?. Eur J Gastroenterol Hepatol. 2003;15:539–543
  28. Makkonen J, Pietiläinen KH, Rissanen A, Kaprio J, Yki-Järvinen H. Genetic factors contribute to variation in serum alanine aminotransferase activity independent of obesity and alcohol: a study in monozygotic and dizygotic twins. J Hepatol. 2009;50:1035–1042

PII: S0168-8278(10)00330-2

doi: 10.1016/j.jhep.2010.02.034

Journal of Hepatology
Volume 53, Issue 2 , Pages 335-338 , August 2010

Article Tools

* Image Usage & Resolution